PHARMAC performance 2018/19 Q1
Performance data to 30 September 2018
Output Class 1: Decision-making
Measure: Savings are generated to meet the cost of future volume growth and allow for new investments.
Status: On track. Savings are generated to meet the cost of future volume growth and allow for new investments.
Measure: The total value and number of hospital medical devices under contract increases.
Status: On track. The Pharmaceutical Schedule increased by around 9,300 line items in the first quarter. Contract value by 1 October 2018 was approximately $195 to $205 million per annum (an increase of $15 to $20 million in the first quarter).
Output Class 2: Influencing medicines use
Measure: DHB hospital engagement with PHARMAC compared with previous year.
Status: On track. All DHBs continue to receive new contracts for medical device products which provide potential for further savings opportunities.
Measure: Survey of attendants at a PHARMAC Seminar show a positive professional change in optimal use behaviour as a result of attendance.
Status: On track. Five seminars from 2018/19 have been surveyed. Surveys to assess change are sent 2-3 months after Seminar, so no behaviour change surveys have been completed yet.
Measure: Medicines use community health programmes are delivered to a range of health and community workers.
Status: On track. Planning for community-based delivery of programmes has occurred in over half of all Whānau Ora Collective (WOC) partner areas for Quarter 1. The number of WOC partners has remained static.
Measure: Low medicine stock situations are identified and managed so that there are no clinically meaningful consequences to patients.
Status: On track. PHARMAC has worked with suppliers to identify, monitor and manage all low medicine stock reports.
Output Class 3: Providing policy advice and support
Measure: PHARMAC staff participate in and contribute to wider sector forums.
Status: On track. PHARMAC continues to actively instigate and participate in various engagements across the health sector.
Measure: All rebates are collected and distributed to DHBs in accordance with PHARMAC policy.
Status: On track. All PHARMAC fund use is in accordance with PHARMAC policy.
Last updated: 18 December 2018